PRLB

SEC source: 0001628280-26-063573 · wk-form4_1790367067.xml · nonDerivative · entry 1

Schumacher Daniel · CIK 0001894753 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,019

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026.

F2 · price: Reflects the weighted average price of 5,000 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on September 24, 2026, with sale prices ranging from $95.00 to $95.65 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-26-062704 · wk-form4_1789761748.xml · nonDerivative · entry 2

Schumacher Daniel · CIK 0001894753 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,019

F1 · kind: This transaction was executed pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person on June 5, 2026.

F2 · price: Reflects the weighted average price of 4,900 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on September 17, 2026, with sale prices ranging from $85.00 to $85.50 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-26-062704 · wk-form4_1789761748.xml · nonDerivative · entry 1

Schumacher Daniel · CIK 0001894753 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,919

F1 · kind: This transaction was executed pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person on June 5, 2026.

SEC source: 0001628280-26-040863 · wk-form4_1780606432.xml · nonDerivative · entry 2

WEHRWEIN SVEN · CIK 0001205069 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,505

SEC source: 0001628280-26-040863 · wk-form4_1780606432.xml · nonDerivative · entry 1

WEHRWEIN SVEN · CIK 0001205069 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,005

F1 · price: Reflects the weighted average price of 1,500 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on June 2, 2026, with sale prices ranging from $76.86 to $77.00 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-26-038475 · wk-form4_1779913110.xml · nonDerivative · entry 1

Krishna Suresh · CIK 0001488151 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,147

SEC source: 0001628280-26-037725 · wk-form4_1779480750.xml · nonDerivative · entry 1

Schumacher Daniel · CIK 0001894753 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,019

SEC source: 0001628280-26-037722 · wk-form4_1779480731.xml · derivative · entry 2

Parlange Bernardo · CIK 0002135514 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,789

Underlying: Common Stock · 3,789 shares

Expires 2036-05-20

F2 · derivative.exercise_date: 25% of shares subject to the award will vest on May 20, 2027, and on each May 20th thereafter until all shares subject to the award are fully vested.

SEC source: 0001628280-26-037722 · wk-form4_1779480731.xml · nonDerivative · entry 1

Parlange Bernardo · CIK 0002135514 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,109

F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on May 20, 2027, and on each May 20th thereafter until all shares subject to the award are fully vested.

SEC source: 0001628280-26-037251 · wk-form4_1779394055.xml · nonDerivative · entry 1

Black Archie C. · CIK 0001489095 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,428

F1 · shares: Deferred stock units that vest in full on the earlier of the first anniversary of the grant date or the date of the 2027 Annual Meeting of Shareholders but must be retained until the reporting person's service on the Company's Board of Directors ends.

SEC source: 0001628280-26-037247 · wk-form4_1779394011.xml · nonDerivative · entry 1

Chand Sujeet · CIK 0001388884 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,863

F1 · shares: Deferred stock units that vest in full on the earlier of the first anniversary of the grant date or the date of the 2027 Annual Meeting of Shareholders but must be retained until the reporting person's service on the Company's Board of Directors ends.

SEC source: 0001628280-26-037245 · wk-form4_1779393982.xml · nonDerivative · entry 1

Chin Moonhie · CIK 0001395001 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,306

F1 · shares: Deferred stock units that vest in full on the earlier of the first anniversary of the grant date or the date of the 2027 Annual Meeting of Shareholders but must be retained until the reporting person's service on the Company's Board of Directors ends.

SEC source: 0001628280-26-037243 · wk-form4_1779393959.xml · nonDerivative · entry 1

Gawlick Rainer · CIK 0001542473 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,093

F1 · shares: Deferred stock units that vest in full on the earlier of the first anniversary of the grant date or the date of the 2027 Annual Meeting of Shareholders but must be retained until the reporting person's service on the Company's Board of Directors ends.

SEC source: 0001628280-26-037234 · wk-form4_1779393912.xml · nonDerivative · entry 1

WEHRWEIN SVEN · CIK 0001205069 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,505

F1 · shares: Deferred stock units that vest in full on the earlier of the first anniversary of the grant date or the date of the 2027 Annual Meeting of Shareholders but must be retained until the reporting person's service on the Company's Board of Directors ends.

SEC source: 0001628280-26-037232 · wk-form4_1779393889.xml · nonDerivative · entry 1

KRANTZ DONALD G · CIK 0001183159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,863

F1 · shares: Restricted stock units that vest in full on the earlier of the first anniversary of the grant date or the date of the 2027 Annual Meeting of Shareholders.

SEC source: 0001628280-26-034651 · wk-form4_1778704834.xml · derivative · entry 15

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,042 shares

Expires 2032-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested.

SEC source: 0001628280-26-034651 · wk-form4_1778704834.xml · derivative · entry 14

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,674

Underlying: Common Stock · 1,557 shares

Expires 2035-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: 25% of shares subject to the award will vest on February 25, 2026, and on each February 25th thereafter until all shares subject to the award are fully vested.

SEC source: 0001628280-26-034651 · wk-form4_1778704834.xml · derivative · entry 13

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,928

Underlying: Common Stock · 1,928 shares

Expires 2033-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: 25% of shares subject to the award will vest on February 13, 2024, and on each February 13th thereafter until all shares subject to the award are fully vested.

SEC source: 0001628280-26-034651 · wk-form4_1778704834.xml · nonDerivative · entry 10

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,683

F6 · price: Reflects the weighted average price of 6,643 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on May 12, 2026, with sale prices ranging from $70.13 to $70.57 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-26-034651 · wk-form4_1778704834.xml · nonDerivative · entry 9

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,326

F5 · price: Reflects the weighted average price of 3,576 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on May 12, 2026, with sale prices ranging from $69.13 to $70.1181 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-26-034651 · wk-form4_1778704834.xml · nonDerivative · entry 8

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,902

F4 · price: Reflects the weighted average price of 4,198 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on May 12, 2026, with sale prices ranging from $68.10 to $69.0425 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-26-034651 · wk-form4_1778704834.xml · nonDerivative · entry 7

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,100

F3 · price: Reflects the weighted average price of 1,613 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on May 12, 2026, with sale prices ranging from $67.06 to $68.05 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-26-034651 · wk-form4_1778704834.xml · nonDerivative · entry 6

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,713

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-26-034651 · wk-form4_1778704834.xml · nonDerivative · entry 5

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,671

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-26-034651 · wk-form4_1778704834.xml · nonDerivative · entry 4

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,114

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-26-034651 · wk-form4_1778704834.xml · derivative · entry 12

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,778

Underlying: Common Stock · 3,677 shares

Expires 2034-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were acquired and sold pursuant to Reporting Person's 10b5-1 plan adopted August 15, 2025.

F8 · derivative.exercise_date: 25% of shares subject to the award will vest on February 13, 2025, and on each February 13th thereafter until all shares subject to the award are fully vested.

SEC source: 0001628280-26-034651 · wk-form4_1778704834.xml · derivative · entry 11

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,856

Underlying: Common Stock · 3,756 shares

Expires 2033-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were acquired and sold pursuant to Reporting Person's 10b5-1 plan adopted August 15, 2025.

F7 · derivative.exercise_date: 25% of shares subject to the award will vest on February 13, 2024, and on each February 13th thereafter until all shares subject to the award are fully vested.

SEC source: 0001628280-26-034651 · wk-form4_1778704834.xml · nonDerivative · entry 3

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,186

F1 · kind: These shares were acquired and sold pursuant to Reporting Person's 10b5-1 plan adopted August 15, 2025.

F2 · price: Reflects the weighted average price of 7,433 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on May 11, 2026, with sale prices ranging from $70.00 to $70.57 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-26-034651 · wk-form4_1778704834.xml · nonDerivative · entry 2

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,619

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were acquired and sold pursuant to Reporting Person's 10b5-1 plan adopted August 15, 2025.

SEC source: 0001628280-26-034651 · wk-form4_1778704834.xml · nonDerivative · entry 1

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,942

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were acquired and sold pursuant to Reporting Person's 10b5-1 plan adopted August 15, 2025.

SEC source: 0001628280-26-032958 · wk-form4_1778272404.xml · derivative · entry 5

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,455

Underlying: Common Stock · 100 shares

Expires 2034-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were acquired and sold pursuant to Reporting Person's 10b5-1 plan adopted August 15, 2025.

F3 · derivative.exercise_date: 25% of shares subject to the award will vest on February 13, 2025, and on each February 13th thereafter until all shares subject to the award are fully vested.

SEC source: 0001628280-26-032958 · wk-form4_1778272404.xml · derivative · entry 4

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,612

Underlying: Common Stock · 100 shares

Expires 2033-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were acquired and sold pursuant to Reporting Person's 10b5-1 plan adopted August 15, 2025.

F2 · derivative.exercise_date: 25% of shares subject to the award will vest on February 13, 2024, and on each February 13th thereafter until all shares subject to the award are fully vested.

SEC source: 0001628280-26-032958 · wk-form4_1778272404.xml · nonDerivative · entry 3

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,186

F1 · kind: These shares were acquired and sold pursuant to Reporting Person's 10b5-1 plan adopted August 15, 2025.

SEC source: 0001628280-26-032958 · wk-form4_1778272404.xml · nonDerivative · entry 2

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,386

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were acquired and sold pursuant to Reporting Person's 10b5-1 plan adopted August 15, 2025.

SEC source: 0001628280-26-032958 · wk-form4_1778272404.xml · nonDerivative · entry 1

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,286

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These shares were acquired and sold pursuant to Reporting Person's 10b5-1 plan adopted August 15, 2025.

SEC source: 0001628280-26-012831 · wk-form4_1772226970.xml · derivative · entry 3

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,404

Underlying: Common Stock · 4,404 shares

Expires 2036-02-25

F2 · derivative.exercise_date: 25% of shares subject to the award will vest on February 25, 2027, and on each February 25th thereafter until all shares subject to the award are fully vested.

SEC source: 0001628280-26-012831 · wk-form4_1772226970.xml · nonDerivative · entry 2

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,186

SEC source: 0001628280-26-012831 · wk-form4_1772226970.xml · nonDerivative · entry 1

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,717

F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 25, 2027, and on each February 25th thereafter until all shares subject to the award are fully vested.

SEC source: 0001628280-26-012832 · wk-form4_1772226994.xml · derivative · entry 3

Schumacher Daniel · CIK 0001894753 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,605

Underlying: Common Stock · 5,605 shares

Expires 2036-02-25

F2 · derivative.exercise_date: 25% of shares subject to the award will vest on February 25, 2027, and on each February 25th thereafter until all shares subject to the award are fully vested.

SEC source: 0001628280-26-012832 · wk-form4_1772226994.xml · nonDerivative · entry 2

Schumacher Daniel · CIK 0001894753 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,274

SEC source: 0001628280-26-012832 · wk-form4_1772226994.xml · nonDerivative · entry 1

Schumacher Daniel · CIK 0001894753 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,778

F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 25, 2027, and on each February 25th thereafter until all shares subject to the award are fully vested.

SEC source: 0001628280-26-012833 · wk-form4_1772227016.xml · derivative · entry 2

Krishna Suresh · CIK 0001488151 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,383

Underlying: Common Stock · 24,383 shares

Expires 2036-02-25

F2 · derivative.exercise_date: 25% of shares subject to the award will vest on February 25, 2027, and on each February 25th thereafter until all shares subject to the award are fully vested.

SEC source: 0001628280-26-012833 · wk-form4_1772227016.xml · nonDerivative · entry 1

Krishna Suresh · CIK 0001488151 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,394

F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 25, 2027, and on each February 25th thereafter until all shares subject to the award are fully vested.

SEC source: 0001628280-26-012829 · wk-form4_1772226945.xml · derivative · entry 2

Kermisch Marc · CIK 0001975999 · Chief Technology & AI Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,095

Underlying: Common Stock · 5,095 shares

Expires 2036-02-25

F2 · derivative.exercise_date: 25% of shares subject to the award will vest on February 25, 2027, and on each February 25th thereafter until all shares subject to the award are fully vested.

SEC source: 0001628280-26-012829 · wk-form4_1772226945.xml · nonDerivative · entry 1

Kermisch Marc · CIK 0001975999 · Chief Technology & AI Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,513

F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 25, 2027, and on each February 25th thereafter until all shares subject to the award are fully vested.

SEC source: 0001628280-26-009129 · wk-form4_1771450661.xml · nonDerivative · entry 2

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,302

F1 · kind: This transaction was executed pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person on August 15, 2025.

F2 · price: Reflects the weighted average price of 5,000 shares of common stock of Proto Labs Inc. sold by the reporting person in multiple transactions on February 17, 2026, with sale prices ranging from $66.01 to $66.87 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001628280-26-009129 · wk-form4_1771450661.xml · nonDerivative · entry 1

Kenison Michael R. · CIK 0001870293 · Chief Operations Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,302

SEC source: 0001628280-26-009131 · wk-form4_1771450693.xml · nonDerivative · entry 1

Schumacher Daniel · CIK 0001894753 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,704

SEC source: 0001894753-26-000003 · form4-02122026_090244.xml · derivative · entry 3

Schumacher Daniel · CIK 0001894753 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,135 shares

Expires 2026-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested.

SEC source: 0001894753-26-000003 · form4-02122026_090244.xml · nonDerivative · entry 2

Schumacher Daniel · CIK 0001894753 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,971

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.